| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Departments of Preventive Medicine and Community Health [L.-J. W. L., K. E. A., J. J. G.] and Obstetrics and Gynecology [M. N.], The University of Texas Medical Branch, Galveston, Texas 77555, and Department of Biological Regulation, The Weizmann Institute of Science, Rehovot 76100, Israel [F. K.]
Ovarian hormones are biomarkers for breast cancer risk. Soybean consumption may be responsible in part for lower levels of ovarian hormones and decreased rates of breast cancer in women in Asia compared with Western populations. Soybeans contain a significant amount of the isoflavones daidzein and genistein, which are weak estrogens. The purpose of this study was to determine whether soya feeding decreases circulating levels of ovarian hormones and gonadotropins. Ten healthy, regularly cycling women consumed a constant soya-containing diet on a metabolic unit, starting on day 2 of a menstrual cycle until day 2 of the next cycle. Blood and urine samples were obtained daily for one menstrual cycle before and during soy feeding. The diet was calculated to maintain constant body weight, included 400 kilocalories from a 36-ounce portion of soymilk, and provided 113–207 mg/day (154.0 ± 8.4 mg/day, mean ± SE) of total isoflavones. For the group, the soya diet provided more carbohydrate and less protein than the home diets. Daily consumption of the soya diet reduced circulating levels of 17ß-estradiol by 25% (P < 0.01, Wilcoxon signed rank test, two-tailed) and of progesterone by 45% (P < 0.0001) compared with levels during the home diet period but had no effect on luteinizing hormone or follicle-stimulating hormone. Mean menstrual cycle length did not change during the soya diet; a slight decrease in mean luteal cycle length was marginally statistically significant (P = 0.06). Urinary excretion of isoflavones was 33.8 ± 5.3 mg/day (mean ± SE) and when expressed as percentage of intake, varied substantially (21.9 ± 3.3% of intake; range, 9.1–36.7%) among the subjects. Mean daily serum levels of daidzein and genistein (free and conjugated forms) 15 h after soymilk were 2.89 ± 0.53 µg/ml and 0.85 ± 0.22 µg/ml, respectively, indicating systemic bioavailability of these substances. Secondary analyses by multiple regression showed that decreases in follicular and luteal phase 17ß-estradiol levels were positively associated with urinary isoflavone excretion, an association affected by age, and were inversely associated with decreases in protein intake. Decreases in progesterone levels during the soya diet were inversely associated with increases in intakes of genistein and were affected by the interaction of the intakes of daidzein with energy or with fiber. Consumption of an isoflavone-containing soya diet reduced levels of ovarian steroids in normal women over the entire menstrual cycle without affecting gonadotropins. This suggests that at least under the conditions of this study, soya-induced reductions of circulating ovarian steroids are not mediated by gonadotropins. Decreases in ovarian hormones are related to isoflavones contained in soy and also to energy intake and other components such as protein and fiber but not fat. Our results may explain decreased ovarian hormone levels and decreased risk of breast cancer in populations consuming soya diets and have implications for reducing breast cancer risk by dietary intervention.
This article has been cited by other articles:
|
|
 |
|
  B. J. Fuhrman, R. Pfeiffer, X. Xu, A. H. Wu, L. Korde, M. H. Gail, L. K. Keefer, T. D. Veenstra, R. N. Hoover, and R. G. Ziegler Soy Intake is Associated with Increased 2-Hydroxylation and Decreased 16{alpha}-Hydroxylation of Estrogens in Asian-American Women Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2751 - 2760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Moiseeva and M. M. Manson Dietary Chemopreventive Phytochemicals: Too Little or Too Much? Cancer Prevention Research, July 1, 2009; 2(7): 611 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Lee, X.-O. Shu, H. Li, G. Yang, H. Cai, W. Wen, B.-T. Ji, J. Gao, Y.-T. Gao, and W. Zheng Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1920 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Caserta, L. Maranghi, A. Mantovani, R. Marci, F. Maranghi, and M. Moscarini Impact of endocrine disruptor chemicals in gynaecology Hum. Reprod. Update, January 1, 2008; 14(1): 59 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Wood, T. C. Register, and J.M. Cline Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys Carcinogenesis, April 1, 2007; 28(4): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. Okey, and P. Harper Dietary Phytoestrogen Intake Is Associated with Reduced Colorectal Cancer Risk J. Nutr., December 1, 2006; 136(12): 3046 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, J. W Lampe, D. Scholes, C. Chen, K. Wahala, and S. M Schwartz Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Moore, Y. Wang, W. G. Stebbins, D. Gao, X. Zhou, R. Phelps, M. Lebwohl, and H. Wei Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis Carcinogenesis, August 1, 2006; 27(8): 1627 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Wood, T. C. Register, A. A. Franke, M. S. Anthony, and J. M. Cline Dietary Soy Isoflavones Inhibit Estrogen Effects in the Postmenopausal Breast Cancer Res., January 15, 2006; 66(2): 1241 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dave, R. R. Eason, S.R. Till, Y. Geng, M. C. Velarde, T. M. Badger, and R. C.M. Simmen The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN Carcinogenesis, October 1, 2005; 26(10): 1793 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, S. Cao, M. Nagamani, K. E. Anderson, J. J. Grady, and L.-J. W. Lu Decreased Circulating Levels of Tumor Necrosis Factor-{alpha} in Postmenopausal Women during Consumption of Soy-Containing Isoflavones J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3956 - 3962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, J. D. Curry, C. VandeVoort, A. Conley, and M. T. Smith Brown Kelp Modulates Endocrine Hormones in Female Sprague-Dawley Rats and in Human Luteinized Granulosa Cells J. Nutr., February 1, 2005; 135(2): 296 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Eason, M. C. Velarde, L. Chatman Jr, S. R. Till, Y. Geng, M. Ferguson, T. M. Badger, and R. C. M. Simmen Dietary Exposure to Whey Proteins Alters Rat Mammary Gland Proliferation, Apoptosis, and Gene Expression during Postnatal Development J. Nutr., December 1, 2004; 134(12): 3370 - 3377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maskarinec, A. A. Franke, A. E. Williams, S. Hebshi, C. Oshiro, S. Murphy, and F. Z. Stanczyk Effects of a 2-Year Randomized Soy Intervention on Sex Hormone Levels in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1736 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Choi, M. H. Lee, A. E. Bale, D. Carter, and B. G. Haffty Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients J. Clin. Oncol., May 1, 2004; 22(9): 1638 - 1645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D Brooks, W. E Ward, J. E Lewis, J. Hilditch, L. Nickell, E. Wong, and L. U Thompson Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy Am. J. Clinical Nutrition, February 1, 2004; 79(2): 318 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Horn-Ross, E. M. John, A. J. Canchola, S. L. Stewart, and M. M. Lee Phytoestrogen Intake and Endometrial Cancer Risk J Natl Cancer Inst, August 6, 2003; 95(15): 1158 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamamoto, T. Sobue, M. Kobayashi, S. Sasaki, and S. Tsugane Soy, Isoflavones, and Breast Cancer Risk in Japan J Natl Cancer Inst, June 18, 2003; 95(12): 906 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hilakivi-Clarke, E. Cho, A. Cabanes, S. DeAssis, S. Olivo, W. Helferich, M. E. Lippman, and R. Clarke Dietary Modulation of Pregnancy Estrogen Levels and Breast Cancer Risk among Female Rat Offspring Clin. Cancer Res., November 1, 2002; 8(11): 3601 - 3610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, A. A. Franke, F. Jin, X.-O. Shu, J. R. Hebert, L. J. Custer, J. Cheng, Y.-T. Gao, and W. Zheng Urinary Excretion of Phytoestrogens and Risk of Breast Cancer among Chinese Women in Shanghai Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Lemos, C. L. Van Patten, K. A. Gelmon, and I. A. Olivotto Safety Issues of Soy Phytoestrogens in Breast Cancer Patients J. Clin. Oncol., July 1, 2002; 20(13): 3040 - 3042. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kurzer Hormonal Effects of Soy in Premenopausal Women and Men J. Nutr., March 1, 2002; 132(3): 570S - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Ju, C. D. Allred, K. F. Allred, K. L. Karko, D. R. Doerge, and W. G. Helferich Physiological Concentrations of Dietary Genistein Dose-Dependently Stimulate Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) Tumors Implanted in Athymic Nude Mice J. Nutr., November 1, 2001; 131(11): 2957 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Allred, K. F. Allred, Y. H. Ju, S. M. Virant, and W. G. Helferich Soy Diets Containing Varying Amounts of Genistein Stimulate Growth of Estrogen-dependent (MCF-7) Tumors in a Dose-dependent Manner Cancer Res., July 1, 2001; 61(13): 5045 - 5050. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
